Pathogenesis and Targeted Therapy of Epilepsy
Epilepsy is one of the most prevalent neurological disorders and is characterized by recurrent seizures resulting from abnormal neuronal excitability in the central nervous system. Despite the availability of thirty-six antiseizure medications, about one-third of patients with epilepsy do not respon...
| Format: | eBook |
|---|---|
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Subjects: | |
| Online Access: | Open Access: DOAB: description of the publication Open Access: DOAB, download the publication |
| LEADER | 04116namaa2201129uu 4500 | ||
|---|---|---|---|
| 001 | doab98732 | ||
| 003 | oapen | ||
| 005 | 20230405 | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 230405s2023 xx |||||o ||| 0|eng d | ||
| 020 | |a 9783036564364 | ||
| 020 | |a 9783036564371 | ||
| 020 | |a books978-3-0365-6437-1 | ||
| 024 | 7 | |a 10.3390/books978-3-0365-6437-1 |2 doi | |
| 040 | |a oapen |c oapen | ||
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 072 | 7 | |a PSAN |2 bicssc | |
| 720 | 1 | |a N'Gouemo, Prosper |4 edt | |
| 720 | 1 | |a N'Gouemo, Prosper |4 oth | |
| 245 | 0 | 0 | |a Pathogenesis and Targeted Therapy of Epilepsy |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
| 300 | |a 1 online resource (236 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |f Unrestricted online access |2 star | |
| 520 | |a Epilepsy is one of the most prevalent neurological disorders and is characterized by recurrent seizures resulting from abnormal neuronal excitability in the central nervous system. Despite the availability of thirty-six antiseizure medications, about one-third of patients with epilepsy do not respond to the pharmacological treatment and develop a so-called "pharmaco-resistant epilepsy" or "refractory epilepsy." Thus, there is an urgent need to develop novel, effective therapies based on novel mechanisms underlying neuronal excitability that leads to seizures. This reprint's original research papers and review articles highlight unknown mechanisms underlying pharmaco-resistant resistant epilepsy, epileptogenesis, and seizure suppression. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |u https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine and Nursing |2 bicssc | |
| 650 | 7 | |a Neurosciences |2 bicssc | |
| 653 | |a 3-phosphoinositide-dependent protein kinase-1 | ||
| 653 | |a 3CAI | ||
| 653 | |a 4-aminopyridine | ||
| 653 | |a acoustically evoked seizures | ||
| 653 | |a AKT | ||
| 653 | |a AMPA receptor | ||
| 653 | |a anxiety | ||
| 653 | |a astrocyte | ||
| 653 | |a audiogenic epilepsy | ||
| 653 | |a audiogenic kindling | ||
| 653 | |a behavior genetics | ||
| 653 | |a blood-brain barrier | ||
| 653 | |a c-Fos | ||
| 653 | |a cortical atrophy | ||
| 653 | |a cyclosporin A | ||
| 653 | |a cytokine | ||
| 653 | |a EACT | ||
| 653 | |a early gene activation | ||
| 653 | |a epilepsy | ||
| 653 | |a epilepsy model | ||
| 653 | |a epileptogenesis | ||
| 653 | |a fear reaction | ||
| 653 | |a generalized tonic-clonic seizures | ||
| 653 | |a ghrelin | ||
| 653 | |a ghrelin receptor | ||
| 653 | |a GluA1 | ||
| 653 | |a GluR1 | ||
| 653 | |a GRIA1 | ||
| 653 | |a GRIA2 | ||
| 653 | |a hippocampal atrophy | ||
| 653 | |a hippocampus | ||
| 653 | |a immunofluorescence | ||
| 653 | |a inherited epilepsy | ||
| 653 | |a intracerebral electrode | ||
| 653 | |a intractable epilepsy | ||
| 653 | |a lipopolysaccharide | ||
| 653 | |a long-term potentiation | ||
| 653 | |a magnetic resonance imaging | ||
| 653 | |a ML365 | ||
| 653 | |a mural cells | ||
| 653 | |a n/a | ||
| 653 | |a neuroinflammation | ||
| 653 | |a neuronal activity | ||
| 653 | |a neuropsychiatric comorbidity | ||
| 653 | |a PDK1 | ||
| 653 | |a pentylenetetrazole | ||
| 653 | |a pericytes | ||
| 653 | |a pharmacoresistant epilepsy | ||
| 653 | |a PICK1 | ||
| 653 | |a post-traumatic epilepsy | ||
| 653 | |a posttraumatic epilepsy | ||
| 653 | |a protein kinase C | ||
| 653 | |a refractory seizure | ||
| 653 | |a rodents | ||
| 653 | |a seizure susceptibility | ||
| 653 | |a temporal lobe epilepsy | ||
| 653 | |a TMEM1A channels | ||
| 653 | |a traumatic brain injury | ||
| 653 | |a TRPV1 channels | ||
| 653 | |a wild running seizures | ||
| 793 | 0 | |a DOAB Library. | |
| 856 | 4 | 0 | |u https://directory.doabooks.org/handle/20.500.12854/98732 |7 0 |z Open Access: DOAB: description of the publication |
| 856 | 4 | 0 | |u https://mdpi.com/books/pdfview/book/6739 |7 0 |z Open Access: DOAB, download the publication |